Providing dental health services to drug users: Testing a model for a community pharmacy advice and referral scheme

Pharmaceutical Journal

Volumn 271, Issue 7261, 2003, Pages 180-182

  Sheridan, Janie ^a   Carson, Tony ^b   Aggleton, Mark ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Westminster Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

CLINICAL PRACTICE; CONTROLLED STUDY; DENTAL CARE; DRUG MISUSE; DRUG USE; FEAR; FEMALE; HEALTH CARE ACCESS; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; INSTRUMENT STERILIZATION; INTERMETHOD COMPARISON; MALE; MEDICAL AUDIT; NEEDLE; OUTCOMES RESEARCH; PATIENT COUNSELING; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SATISFACTION; PHARMACIST; PHARMACY; PRESCRIPTION; QUESTIONNAIRE; REVIEW; STATISTICAL MODEL; SYRINGE;

EID: 0042389708     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Metsch LR, Crandall L, Wohler-Torres B, Miles CC, Chitwood DD, McCoy CB. Met and unmet need for dental services among active drug users in Miami, Florida. J Behavioral Health Services Res 2002;29:176-88.
2. Sheridan J, Aggleton M, Carson T. Dental health and access to dental treatment: a comparison of drug users and non-drug users attending community pharmacies. Br Dent J 2001;191:453-57.
3. Scheuts F. Dental health in a group of drug addicts attending an addiction-clinic. Community Dent Oral Epidemiol 1984; 12:23-8.
4. Molendijk B, ter Horst G, Kasbergen M, Truin GJ, Mulder J. Dental health in Dutch drug addicts. Community Dent Oral Epidemiol 1996;24:117-19
5. Scheutz F. Five-year evaluation of a dental care delivery system for drug addicts in Denmark. Community Dent Oral Epidemiol 1984;12:29-34.
6. Dawkes M, Sparkes S, Smith M. Dentists' responses to drug misusers. Health Trends 1995;27:12-14.
7. Glanz A. Findings of a national survey of the role of general practitioners in the treatment of opiate misuse: views on treatment. Br Med J 1986;293:543-5.
8. Sheridan J, Strang J, Taylor C, Barber N. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training. Addiction 1997;92:1737-48.
9. Sheridan J, Strang J, Barber N, Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. Br Med J 1996;313:272-4.
10. Luger L, Bathia N, Alcorn R, Power R. Involvemtn of community pharmacists in the care of drug misusers: pharmacy-based supervision of methadone consumption Int J Drug Policy 2000;11:227-34.
11. Matheson C, Bond CM, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction 2002;97:1405-11.
12. Anderson, C. Health promotion by community pharmacists: perceptions, realities and constraints. J Soc Admin Pharm 1998;15:10-22.
13. Blenkinshopp A. Closer working between health professionals: future for medicines management. Int J Pharm Pract 1998;6:119.
14. ter Horst G, Molendijk G, Tjong EJ. [Dental referrral of drug addicts] Ned Tijdschr Tandheelkd 1994;101:406-8.
15. Deehan A, Taylor C, Strang J. The general practitioner, the drug misuser and the alcohol misuser: major differences in general practitioner activity, therapeutic commitment, and shared care proposals. Br J Gen Pract 1997;47:705-9.
16. Freeman R. Barriers to accessing dental care: patient factors. Br Dent J 1999;187:141-4.
17. Maguire TA, Morrow NC, Orr R. Foot care as a focus for health promotion in community pharmacy. Pharm J 1987;239:465-7.
18. Soares MA, Gustafsen I. WHO EuroPharm Forum task force on diabetes care (CPS-P-238). International Pharmaceutical Federation Congress. Int Pharm Abtracts 2002;62:86.
19. Elliott ME, Meek PD, Kanous NL, Shill GR, Weinswig PA, Bohlman JP, et al. Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother 2002;36:571-7.
20. Cairns CJ, Hall J. Promoting cardiac health in the community pharmacy. American Society of Health-System Pharmacists Midyear Clinical Meeting. 1998. Abstract no P-63E.
21. McKenney JM. Evaluation of cholesterol screening in community pharmacies. Am Pharm 1993;NS33[Jul]:34-40.
22. Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy 2001;21:627-35.